According to Steve Pearson, MD, MSc, president of the Institute for Clinical and Economic Review (ICER), patient perspectives are critical for determining meaningful outcomes and helping to guide the cost-effectiveness review process.
According to Steve Pearson, MD, MSc, president of the Institute for Clinical and Economic Review (ICER), patient perspectives are critical for determining meaningful outcomes and helping to guide the cost-effectiveness review process.
Transcript (slightly modified)
How does ICER work to incorporate patient perspectives into its value frameworks?
Patient perspectives, in a sense, guide almost every step we take in our report process. At the very beginning, when we’re just thinking of which topics to do, we reach out to patient groups to make sure, as part of what we call our scoping phase, that we really understand what living with the condition is like from their perspective. We know that they have heard policy makers sometimes, if it’s an organized patient group, they’ve heard policy makers, they’ve heard clinicians sometimes get it wrong, where they don’t understand the full spectrum. They don’t understand what really matters most to patients.
Now, we always have questions of our own. We want to know, for instance, specifically, are there clinical outcome measures that are in the clinical trials that they think are more important to the patients than others, so that they can help us prioritize those. Again, that’s a really critical part because that feeds into every step of our process from the review of clinical excellence through to the cost-effectiveness model.
We establish those relationships, we try to make sure we get a diverse set of patients and patient groups by reaching out to as many as we can find, and then again at that scoping phase, it’s critical. We also feed back to them our early results and make sure that they get a chance to have input. We often have, in a sense, a patient expert be one of the official reviewers of our draft report before it goes out for more full public comment.
That all happens before we even have our public meeting, which is the other place where we bring all stakeholders together, but patients and the clinical experts have a very important role right at the beginning of the day, where they often are involved as the summary of the evidence is being presented, and they’re given the opportunity to lend nuance to that, to give a broader perspective, if you will.
Then, they sit at the table as our independent counsels discuss the evidence and start to get ready to vote, so that if questions come up, they’re right there in the midst of the conversation to be able to help lend that broader perspective, and sometimes answer very specific questions about key issues of evidence and value from the patient’s perspective.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More